Location: NEW YORK, NY
CIK: 0002102314 · Show all filings
Period: Q1 2026
Filing Date: May 14, 2026
Total Value ($000): $466,471 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| BMRN | BIOMARIN PHARMACEUTICAL INC | 1,268,390 | $71,651 | 15.4% | $58.72 | 0.0% | COM | 09061G101 |
| VRTX | VERTEX PHARMACEUTICALS INC | 108,603 | $48,496 | 10.4% | $467.55 | 0.0% | COM | 92532F100 |
| PCVX | VAXCYTE INC | 644,831 | $37,471 | 8.0% | $52.77 | 0.0% | COM | 92243G108 |
| NUVL | NUVALENT INC | 300,830 | $30,820 | 6.6% | $103.64 | 0.0% | COM | 670703107 |
| CAPR | CAPRICOR THERAPEUTICS INC | 909,207 | $27,640 | 5.9% | $24.88 | 0.0% | COM NEW | 14070B309 |
| TERN | TERNS PHARMACEUTICALS INC | 521,237 | $27,480 | 5.9% | $37.46 | 0.0% | COM | 880881107 |
| BCAX | BICARA THERAPEUTICS INC | 1,260,136 | $25,064 | 5.4% | $16.29 | 0.0% | COM | 055477103 |
| ANIP | ANI PHARMACEUTICALS INC | 318,591 | $24,500 | 5.3% | $80.37 | 0.0% | COM | 00182C103 |
| RARE | ULTRAGENYX PHARMACEUTICAL IN | 1,165,557 | $24,418 | 5.2% | $23.36 | 0.0% | COM | 90400D108 |
| ELVN | ENLIVEN THERAPEUTICS INC | 593,040 | $23,247 | 5.0% | $25.60 | 0.0% | COM | 29337E102 |
| AMLX | AMYLYX PHARMACEUTICALS INC | 1,598,794 | $22,223 | 4.8% | $13.99 | 0.0% | COM | 03237H101 |
| ARGX | ARGENX SE | 25,995 | $18,983 | 4.1% | $730.25 | — | SPONSORED ADR | 04016X101 |
| FULC | FULCRUM THERAPEUTICS INC | 1,771,926 | $13,591 | 2.9% | $10.37 | 0.0% | COM | 359616109 |
| VIR | VIR BIOTECHNOLOGY INC | 1,198,213 | $10,736 | 2.3% | $7.20 | 0.0% | COM | 92764N102 |
| NUVB | NUVATION BIO INC | 2,383,031 | $10,223 | 2.2% | $6.19 | 0.0% | COM CL A | 67080N101 |
| ORKA | ORUKA THERAPEUTICS INC | 140,843 | $6,908 | 1.5% | $32.45 | 0.0% | COM | 687604108 |
| CTNM | CONTINEUM THERAPEUTICS INC | 513,053 | $6,700 | 1.4% | $13.35 | 0.0% | CL A | 21217B100 |
| MANE | VERADERMICS INC | 100,843 | $6,368 | 1.4% | $63.15 | — | COMMON STOCK | 922967104 |
| TNXP | TONIX PHARMACEUTICALS HLDG C | 452,116 | $6,217 | 1.3% | $16.19 | 0.0% | COM NEW | 890260839 |
| GPCR | STRUCTURE THERAPEUTICS INC | 100,593 | $4,849 | 1.0% | $48.20 | — | SPONSORED ADS | 86366E106 |
| TRDA | ENTRADA THERAPEUTICS INC | 374,010 | $4,720 | 1.0% | $12.62 | — | COM | 29384C108 |
| PHVS | PHARVARIS N V | 167,014 | $4,718 | 1.0% | $26.74 | 0.0% | COM | N69605108 |
| TRVI | TREVI THERAPEUTICS INC | 370,175 | $4,416 | 0.9% | $10.94 | 0.0% | COM | 89532M101 |
| RLMD | RELMADA THERAPEUTICS INC | 342,752 | $2,386 | 0.5% | $4.01 | 0.0% | COM | 75955J402 |
| SLN | SILENCE THERAPEUTICS PLC | 301,604 | $1,589 | 0.3% | $5.27 | — | ADS | 82686Q101 |
| AVBP | ARRIVENT BIOPHARMA INC | 45,809 | $1,057 | 0.2% | $22.06 | 0.0% | COM | 04272N102 |